Wendy E. McDermott - 28 Feb 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Human Resources
Signature
/s/ Wendy E. McDermott
Issuer symbol
LXRX
Transactions as of
28 Feb 2024
Net transactions value
-$58,754
Form type
4
Filing time
29 Feb 2024, 16:31:43 UTC
Previous filing
12 Feb 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +18,944 +67% 47,422 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +27,697 +58% 75,119 28 Feb 2024 Direct F1
transaction LXRX Common Stock Tax liability $58,754 -22,425 -30% $2.62 52,694 28 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -18,944 -50% 18,943 28 Feb 2024 Common Stock 18,944 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -27,697 -33% 55,393 28 Feb 2024 Common Stock 27,697 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.